NASDAQ: CNTA

Financial Scores

CNTA’s price-to-free cash flow ratio: A closer look at its relevance

Cameron Mitchell

Centessa Pharmaceuticals plc ADR (CNTA)’s stock has witnessed a price declined of -0.18% from the previous close with its current ...

Financial Scores

CNTA’s price-to-sales ratio: Is it a good investment opportunity?

Cameron Mitchell

Centessa Pharmaceuticals plc ADR (CNTA)’s stock has witnessed a price declined of -1.81% from the previous close with its current ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.